Last updated: 2026-09-16 10:32:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
AtaiBeckley Inc. (ATAI) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $7,36, with a market capitalisation of $2,73B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3,27 to $7,45. This page covers its latest market performance, valuation, price trends and company information.
$2,73B | |
$7,31 | |
$22,91 | |
$0,82 | |
$7,29 | |
8,79M | |
14,37M | |
-- | |
$7,45 | |
$3,27 | |
-- | |
-- |
AtaiBeckley Inc. (ATAI) is trading at $7,31 in pre-market trading as of 2026-09-10 23:49:00, up 0,23% ($0,02) from the previous close of $7,29
Pre-market trading shows how investors are pricing ATAI before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.
Over the past seven days, AtaiBeckley Inc. (ATAI) moved from $7,34 to $7,36, representing a gain of 0,20% ($0,02).
The stock traded between $7,23 and $7,43 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.
The average daily volume was 26,92 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 97,7%
ATAI is currently trading at $7,36, placing it 97,7% of the way from its 52-week low of $3,27 to its 52-week high of $7,45. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD, and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 99 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of AtaiBeckley Inc. (ATAI) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.